
Loading, please wait...

Loading, please wait...

Capturing specific proteins from complex biological samples remains a significant challenge in medical research. Researchers recently made a major advancement in lysozyme capture technology by developing a hierarchical three-dimensional polymeric nanofibrous aerogel. This innovative scaffold allows for high-capacity and ultraselective capture of lysozymes.
The research team utilized 3-Aminophenylboronic acid (APBA) as a functional monomer. This monomer creates multimodal interaction sites that are essential for recognizing lysozyme. Consequently, the synergy of electrostatic interactions, hydrophobic forces, and π-π stacking leads to superior performance. Specifically, the aerogel achieved an adsorption capacity of 736.90 mg/g. This value significantly exceeds existing state-of-the-art adsorbents. Furthermore, the selectivity coefficient reached an impressive 4.17.
Practical utility was demonstrated through the extraction of lysozymes from raw egg white. Importantly, the process preserves the native conformational integrity of the enzyme. As a result, the extracted lysozymes exhibited potent antibacterial activity against Staphylococcus aureus. This finding is crucial because it confirms that the capture method does not compromise the protein's therapeutic potential. Additionally, molecular simulation methods verified the interaction mechanism at the interface of the imprinted polymers.
Overall, this research provides a feasible idea for designing highly selective adsorbents. Such advancements in protein separation could streamline the production of bioactive enzymes for clinical applications. Moreover, the study illustrates the power of multimodal interactions in molecular imprinting.
The aerogel uses a three-dimensional scaffold and multimodal interactions, such as electrostatic and hydrophobic forces, to achieve much higher capacity and selectivity than traditional materials.
No, the study confirms that the extracted lysozyme maintains its full antibacterial potency against Staphylococcus aureus and its native structural shape.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or professional services. Always consult a qualified healthcare provider for medical concerns. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have engineered a 3D polymeric nanofibrous aerogel for highly selective lysozyme capture. Achieving an adsorption capacity of 736.90 mg/g, this technology preserves the enzyme's antibacterial potency against S. aureus, offering a major advancement in protein separation for pharmaceutical use.
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today